Literature DB >> 1746552

Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2).

F Greenberg1, V Guzzetta, R Montes de Oca-Luna, R E Magenis, A C Smith, S F Richter, I Kondo, W B Dobyns, P I Patel, J R Lupski.   

Abstract

We undertook clinical evaluation (32 cases) and molecular evaluation (31 cases) of unrelated patients affected with Smith-Magenis syndrome (SMS) associated with an interstitial deletion of band p11.2 of chromosome 17. Patients were evaluated both clinically and electrophysiologically for peripheral neuropathy, since markers showing close linkage to one form of Charcot-Marie-Tooth disease (CMT1A) map to this chromosomal region. The common clinical findings were broad flat midface with brachycephaly, broad nasal bridge, brachydactyly, speech delay, and hoarse, deep voice. Fifty-five percent of the patients showed clinical signs (e.g., decreased or absent deep tendon reflexes, pes planus or pes cavus, decreased sensitivity to pain, and decreased leg muscle mass) suggestive of peripheral neuropathy. However, unlike patients with CMT1A, these patients demonstrated normal nerve conduction velocities. Self-destructive behaviors, primarily onychotillomania and polyembolokoilamania, were observed in 67% of the patients, and significant symptoms of sleep disturbance were observed in 62%. The absence of REM sleep was demonstrated by polysomnography in two patients. Southern analysis indicated that most patients were deleted for five 17p11.2 markers--FG1 (D17S446), 1516 (D17S258), pYNM67-R5 (D17S29), pA10-41 (D17S71), and pS6.1-HB2 (D17S445)--thus defining a region which appears to be critical to SMS. The deletion was determined to be of paternal origin in nine patients and of maternal origin in six patients. The apparent random parental origin of deletion documented in 15 patients suggests that genomic imprinting does not play a role in the expression of the SMS clinical phenotype. Our findings suggest that SMS is likely a contiguous-gene deletion syndrome which comprises characteristic clinical features, developmental delay, clinical signs of peripheral neuropathy, abnormal sleep function, and specific behavioral anomalies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746552      PMCID: PMC1686451     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

Review 1.  Sleep and dreaming.

Authors:  J A Hobson
Journal:  J Neurosci       Date:  1990-02       Impact factor: 6.167

2.  Three polymorphisms at the D17S29 locus.

Authors:  R Ray; D Rincon-Limas; R A Wright; S N Davis; J R Lupski; P I Patel
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

Review 3.  Genomic imprinting: review and relevance to human diseases.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

4.  Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17.

Authors:  P I Patel; B Franco; C Garcia; S A Slaugenhaupt; Y Nakamura; D H Ledbetter; A Chakravarti; J R Lupski
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

5.  An additional case of deletion 17p11.2.

Authors:  D W Popp; C P Johnson; R F Stratton
Journal:  Am J Med Genet       Date:  1987-02

Review 6.  Benign autosomal dominant syndrome of neuronal Charcot-Marie-Tooth disease, ptosis, parkinsonism, and dementia.

Authors:  R Tandan; R Taylor; A Adesina; K Sharma; T Fries; W Pendlebury
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

7.  Localization of a locus for Charcot-Marie-Tooth neuropathy type Ia (CMT1A) to chromosome 17.

Authors:  P J McAlpine; T E Feasby; A F Hahn; L Komarnicki; S James; C Guy; M Dixon; S Qayyum; J Wright; G Coopland
Journal:  Genomics       Date:  1990-07       Impact factor: 5.736

8.  Linkage of hereditary motor and sensory neuropathy type I to the pericentromeric region of chromosome 17.

Authors:  H R Middleton-Price; A E Harding; C Monteiro; J Berciano; S Malcolm
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

9.  Interstitial deletion of (17)(p11.2p11.2): report of six additional patients with a new chromosome deletion syndrome.

Authors:  R F Stratton; W B Dobyns; F Greenberg; J B DeSana; C Moore; G Fidone; G H Runge; P Feldman; G S Sekhon; R M Pauli
Journal:  Am J Med Genet       Date:  1986-07

10.  The human homeobox gene HOX7 maps to chromosome 4p16.1 and may be implicated in Wolf-Hirschhorn syndrome.

Authors:  A Ivens; N Flavin; R Williamson; M Dixon; G Bates; M Buckingham; B Robert
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

View more
  86 in total

1.  2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture.

Authors:  James R Lupski
Journal:  Am J Hum Genet       Date:  2003-02       Impact factor: 11.025

2.  Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2.

Authors:  Christine J Shaw; Weimin Bi; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-10-09       Impact factor: 11.025

3.  Comparative genomic hybridisation using a proximal 17p BAC/PAC array detects rearrangements responsible for four genomic disorders.

Authors:  C J Shaw; C A Shaw; W Yu; P Stankiewicz; L D White; A L Beaudet; J R Lupski
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

4.  Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2.

Authors:  Weimin Bi; Sung-Sup Park; Christine J Shaw; Marjorie A Withers; Pragna I Patel; James R Lupski
Journal:  Am J Hum Genet       Date:  2003-11-24       Impact factor: 11.025

Review 5.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

6.  Smith-Magenis Syndrome: Face Speaks.

Authors:  Rekha Gupta; Neerja Gupta; Sheela Nampoothiri; Kausik Mandal; Yougal Kishore; Pankaj Sharma; Madhulika Kabra; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2015-12-17       Impact factor: 1.967

7.  Pronounced maternal parent-of-origin bias for type-1 NF1 microdeletions.

Authors:  Lisa Neuhäusler; Anna Summerer; David N Cooper; Victor-F Mautner; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2018-05-05       Impact factor: 4.132

Review 8.  Specific genetic disorders and autism: clinical contribution towards their identification.

Authors:  David Cohen; Nadège Pichard; Sylvie Tordjman; Clarisse Baumann; Lydie Burglen; Elsa Excoffier; Gabriela Lazar; Philippe Mazet; Clément Pinquier; Alain Verloes; Delphine Héron
Journal:  J Autism Dev Disord       Date:  2005-02

9.  Discriminating power of localized three-dimensional facial morphology.

Authors:  Peter Hammond; Tim J Hutton; Judith E Allanson; Bernard Buxton; Linda E Campbell; Jill Clayton-Smith; Dian Donnai; Annette Karmiloff-Smith; Kay Metcalfe; Kieran C Murphy; Michael Patton; Barbara Pober; Katrina Prescott; Pete Scambler; Adam Shaw; Ann C M Smith; Angela F Stevens; I Karen Temple; Raoul Hennekam; May Tassabehji
Journal:  Am J Hum Genet       Date:  2005-10-26       Impact factor: 11.025

10.  COP9 signalosome subunit 3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast.

Authors:  Jiong Yan; Katherina Walz; Hisashi Nakamura; Sandra Carattini-Rivera; Qi Zhao; Hannes Vogel; Ning Wei; Monica J Justice; Allan Bradley; James R Lupski
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.